Vemlidy 25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR04D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,085
Award facts
- Contract value 100% obligated
- $15,085.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,085.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This non-set-aside contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, reflecting the scope of pharmaceutical products distributed through the DLA's medical supply chain to support military and veteran healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant portfolio of federal medical procurement contracts with the Defense Logistics Agency. The company's federal contracting demonstrates extensive capability in delivering brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains through competitively awarded delivery orders. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to serve Defense Health Agency customers and other federal healthcare systems globally, with the ultimate completion date for this specific delivery order set for December 18, 2025.
Quick answers
Who was awarded contract SPE2DR26FR04D?
SPE2DR26FR04D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FR04D worth?
The government has obligated $15,085 on SPE2DR26FR04D.
Is contract SPE2DR26FR04D an order under another contract?
Yes. SPE2DR26FR04D is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR04D competed?
The extent of competition for SPE2DR26FR04D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award